Atlas Trials

A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder

Clinical trial NCT00921063 · COMPLETED

Trial details

NCT number
NCT00921063
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Generalized Anxiety Disorder
Start date
2005-11-01
Primary completion
2006-07-01
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.